March 24, 2020
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
WILMINGTON, Del.–(BUSINESS WIRE)–Ufovax, a spin-off vaccine company from Scripps Research, announced today that the company has successfully extended its patented…